The Hong Kong stock market concluded its trading session with positive momentum, marking the second consecutive day of gains across its three major indices. The Hang Seng Index, the Enterprise Index, and the Hang Seng TECH Index advanced 0.41%, 0.27%, and 0.29% respectively, amid market volatility. Southbound funds recorded a net purchase of HK$4.142 billion, signaling heightened investor activity. In terms of market performance, leading technology stocks generally trended upwards, with Baidu and Meituan appreciating by nearly 2%, and SMIC surging over 4%. Biopharmaceutical stocks shone brightly, as Yifan Pharmaceutical Technology skyrocketed by nearly 23% and Innovent Biologics soared over 17%. Semiconductor chip stocks also witnessed significant gains, fueled by Goldman Sachs' positive outlook on China's semiconductor industry. Catering stocks, led by Haidilao's 6% surge, remained active throughout the day. Conversely, non-ferrous metal stocks, particularly those related to copper, experienced collective corrections due to overnight downward pressure on copper prices. On the news front, China's catering revenue reached RMB 5.5718 trillion in 2024, marking a 5.3% year-on-year increase. Additionally, the introduction of the "Special Action Plan to Boost Consumption" infused fresh energy into the consumer market. According to Huatai Securities' research report, the Hong Kong stock market continues to be underpinned by several factors, including the better-than-expected earnings of technology companies, the development of the AI industry, and innovative drugs. In the medium to long term, the firm remains optimistic about the revaluation of Chinese assets. From an operational perspective, it is advisable to focus on sectors such as technology revaluation, new consumption, innovative drugs, and high dividends to capitalize on emerging market opportunities.